malates - CISMeF

Preferred Label : malates;

MeSH definition : Derivatives of malic acid (the structural formula: (COO-)2CH2CHOH), including its salts and esters.;

Wikipedia automatic translation : Malic acid;

MeSH annotation : do not confuse with MALEATES;

Wikipedia link : https://en.wikipedia.org/wiki/Malic acid;

Is substance : O;

Détails

Origin ID

D008293;

UMLS CUI

C0024546;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Macroscopic Findings Laterality [NCIt concept]
- Malate [LOINC component]
- Malic acid (substance) [SNOMED CT concept]
Record concept(s)
- malates [MeSH concept]
Related MeSH Supplementary Concept(s)
- (S)-malic acid 1'-O-beta-gentiobioside [MeSH Supplementary Concept]
- (S)-malic acid 1-O-D-glucopyranoside [MeSH Supplementary Concept]
- 1-O-malylglucose [MeSH Supplementary Concept]
- 2-O-sinapoylmalate [MeSH Supplementary Concept]
- 2-benzylmalic acid [MeSH Supplementary Concept]
- 2-isopropylmalic acid [MeSH Supplementary Concept]
- 2-phosphinomethylmalic acid [MeSH Supplementary Concept]
- 3,3-dimethylmalic acid [MeSH Supplementary Concept]
- 3-fluoromalic acid [MeSH Supplementary Concept]
- 3-isopropylmalate methyl ester [MeSH Supplementary Concept]
- 3-isopropylmalic acid [MeSH Supplementary Concept]
- PF-06649298 [MeSH Supplementary Concept]
- PF-06761281 [MeSH Supplementary Concept]
- R116301 [MeSH Supplementary Concept]
- alpha-isopropylmalate [MeSH Supplementary Concept]
- benzoic acid, malic acid, propylene glycol, salicylic acid drug combination [MeSH Supplementary Concept]
- beta-isopropylmalate [MeSH Supplementary Concept]
- beta-methylmalate [MeSH Supplementary Concept]
- bis(4-(glucopyranosyloxy)benzyl) 2-sec-butylmalate [MeSH Supplementary Concept]
- caffeoylmalic acid [MeSH Supplementary Concept]
- calcium citrate malate [MeSH Supplementary Concept]
- chitosan malate [MeSH Supplementary Concept]
- citramalate [MeSH Supplementary Concept]
- citrulline malate [MeSH Supplementary Concept]
- di-n-butylmalate [MeSH Supplementary Concept]
- diaminoplatinum(II)malate [MeSH Supplementary Concept]
- diethyl malate [MeSH Supplementary Concept]
- dimethylcitraconate [MeSH Supplementary Concept]
- eucomic acid 1-methyl ester [MeSH Supplementary Concept]
- feruloylmalic acid [MeSH Supplementary Concept]
- kalanchosine dimalate [MeSH Supplementary Concept]
- malic acid [MeSH Supplementary Concept]
- p-coumaroylmalic acid [MeSH Supplementary Concept]
- pantocin B [MeSH Supplementary Concept]
- phaselic acid [MeSH Supplementary Concept]
- poly(1,8-octanediol malate) [MeSH Supplementary Concept]
- poly(L-lactide-co-beta-malic acid) [MeSH Supplementary Concept]
- poly(malate) [MeSH Supplementary Concept]
- poly(malic acid) [MeSH Supplementary Concept]
- poly-glycerol malate co-dodecanedioate [MeSH Supplementary Concept]
- super malic [MeSH Supplementary Concept]
- technetium tc 99m citramalic acid [MeSH Supplementary Concept]
- vandateroside I [MeSH Supplementary Concept]
- vandateroside II [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients